A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
Condition(s):Muscle-invasive Urothelial CarcinomaLast Updated:March 22, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Muscle-invasive Urothelial CarcinomaLast Updated:March 22, 2023Not yet recruiting
Condition(s):Ovarian Squamous Cell CarcinomaLast Updated:February 22, 2023Not yet recruiting
Condition(s):Solid TumorLast Updated:February 21, 2023Not yet recruiting
Condition(s):Family Centered Care; Decision MakingLast Updated:March 15, 2023Recruiting
Condition(s):Heart FailureLast Updated:March 10, 2023Recruiting
Condition(s):ST-segment Elevation Myocardial Infarction (STEMI)Last Updated:March 1, 2023Recruiting
Condition(s):Effect of FoodLast Updated:February 28, 2023Recruiting
Condition(s):Retinopathy of Prematurity; Newborns; InfantsLast Updated:March 13, 2023Not yet recruiting
Condition(s):Chronic ConstipationLast Updated:March 9, 2023Terminated
Condition(s):Hyperphosphatemia Patients on HemodialysisLast Updated:February 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.